Quick Picks - Despite a new drug approval on Friday, Teva Pharmaceuticals (NYSE:TEVA) declined slightly in the trading session. The FDA approved Synribo as a treatment for Chronic … Continue Reading
Read NowQuick Picks - Word from Orexigen Therapeutics (NASDAQ:OREX) Wednesday that it will be raising capital in the form of an equity offering came as little surprise to investors, … Continue Reading
Read NowQuick Picks - While Discovery Laboratories (NASDAQ:DSCO) maintains that Afectair will hit the market in December, the launch of Surfaxin has been delayed until at least the second … Continue Reading
Read NowQuick Picks - Price targets are rising for Questcor Pharmaceuticals (NASDAQ:QCOR) on Wednesday following the company’s third quarter earnings beat. The revised sell-side expectations support PropThink’s target price … Continue Reading
Read NowQuick Picks - United Therapeutics Corporation (NADSAQ:UTHR) announced after hours on Tuesday that it’s application for an oral formulation of Remodulin (treprostinil) received a Complete Response Letter (CRL) from the … Continue Reading
Read NowQuick Picks - The competition among obesity-drug makers continues to heat up Monday following an announcement from Orexigen Therapeutics (NASDAQ:OREX) that the company may be able to expedite the approval … Continue Reading
Read NowQuick Picks - In an all-stock merger announced Thursday morning, BioCryst Pharmaceuticals (NASDAQ:BCRX) will acquire privately-held Presidio, Inc, creating a new business entity to focus on oral Hepatitis … Continue Reading
Read Now